Abstract Background The COVID-19 pandemic is creating severe issues for healthcare and broad social structures, exposing societal vulnerabilities. Among the populations affected by are people engaged in substance use, such as who smoke; vape (e-cigarette use); use opioids, cannabis, alcohol, or psychoactive prescription drugs; have a disorder (SUD). Monitoring SUD during essential, engage prese...